摘要
纳米医学近期作为一种能够改善多种难治或与年龄相关的大脑紊乱疾病的早期诊断与治疗的令人兴奋的工具出现。纳米材料的最相关性质是他们能够被设计通过血脑屏障,把特殊的细胞和分子作为靶点,充当药物的载体。与传统医学相比,独特纳米疗法的潜在益处包括提高疗效、安全性、灵敏度和个性化。本篇综述描述了纳米结构和纳米材料可应用于大脑方面的研究进展。其次,综述了纳米技术用于神经系统疾病诊断和治疗的最新应用,尤其是脑肿瘤和神经退行性疾病。总结了纳米材料体内外神经毒性的近期研究。最后,讨论了如果新的纳米医学产品投放市场必须面对的持续挑战,概括了一些未来的研究方向。
关键词: 阿尔茨海默病,脑肿瘤,诊断,工程纳米材料,纳米科技,纳米技术,帕金森病
Current Medicinal Chemistry
Title:Diagnostic and Therapeutic Uses of Nanomaterials in the Brain
Volume: 21 Issue: 36
Author(s): Elisa Garbayo, Ander Estella-Hermoso de Mendoza and Maria J. Blanco-Prieto
Affiliation:
关键词: 阿尔茨海默病,脑肿瘤,诊断,工程纳米材料,纳米科技,纳米技术,帕金森病
摘要: Nanomedicine has recently emerged as an exciting tool able to improve the early diagnosis and treatment of a variety of intractable or age-related brain disorders. The most relevant properties of nanomaterials are that they can be engineered to cross the blood brain barrier, to target specific cells and molecules and to act as vehicles for drugs. Potentially beneficial properties of nanotherapeutics derived from its unique characteristics include improved efficacy, safety, sensitivity and personalization compared to conventional medicines. In this review, recent advances in available nanostructures and nanomaterials for brain applications will be described. Then, the latest applications of nanotechnology for the diagnosis and treatment of neurological disorders, in particular brain tumors and neurodegenerative diseases, will be reviewed. Recent investigations of the neurotoxicity of the nanomaterial both in vitro and in vivo will be summarized. Finally, the ongoing challenges that have to be meet if new nanomedical products are to be put on the market will be discussed and some future directions will be outlined.
Export Options
About this article
Cite this article as:
Garbayo Elisa, Mendoza Estella-Hermoso de Ander and Blanco-Prieto J. Maria, Diagnostic and Therapeutic Uses of Nanomaterials in the Brain, Current Medicinal Chemistry 2014; 21 (36) . https://dx.doi.org/10.2174/0929867321666140815124246
DOI https://dx.doi.org/10.2174/0929867321666140815124246 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Blocking Ca2+ Entry: A Way to Control Cell Proliferation
Current Medicinal Chemistry Targeting Heat Shock Proteins 70/90 and Proteasome for Cancer Therapy
Current Medicinal Chemistry Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview
Anti-Cancer Agents in Medicinal Chemistry Anticancer Agents Derived from Natural Products
Mini-Reviews in Medicinal Chemistry The Membrane-targeted Alkylphosphocholine Erufosine Interferes with Survival Signals from the Extracellular Matrix
Anti-Cancer Agents in Medicinal Chemistry Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents
Anti-Cancer Agents in Medicinal Chemistry Rational Drug Design of G-Quartet DNA as Anti-Cancer Agents
Current Pharmaceutical Design Betulinic Acid as a Potent and Complex Antitumor Phytochemical: A Minireview
Anti-Cancer Agents in Medicinal Chemistry Aquaporins and Glia
Current Neuropharmacology Neuropeptide-Derived Antimicrobial Peptides from Invertebrates for Biomedical Applications
Current Medicinal Chemistry Hemisynthesis of Selected Embelin Analogs and Investigation of their Proapoptotic Activity Against Cancer Cells
Medicinal Chemistry Signaling Pathways Regulating Gliomagenesis
Current Molecular Medicine Advances Towards The Discovery of GPR55 Ligands
Current Medicinal Chemistry Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Recent Patents on CNS Drug Discovery (Discontinued) Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression
Current Bioinformatics Bio-Inspired Algorithms Applied to Molecular Docking Simulations
Current Medicinal Chemistry iRGD Co-Administration with Paclitaxel-Loaded PLGA Nanoparticles Enhance Targeting and Antitumor Effect in Colorectal Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Natural Killer Cells: Prospects in Cancer Immunotherapy
Current Immunology Reviews (Discontinued) Advancing the Therapeutic Efficacy of Bioactive Molecules by Delivery Vehicle Platforms
Current Medicinal Chemistry